Vista Pharmaceuticals reports standalone net loss of Rs 1.29 crore in the June 2025 quarter
Sales decline 15.56% to Rs 1.52 crore
Net Loss of Vista Pharmaceuticals reported to Rs 1.29 crore in the quarter ended June 2025 as against net loss of Rs 0.86 crore during the previous quarter ended June 2024. Sales declined 15.56% to Rs 1.52 crore in the quarter ended June 2025 as against Rs 1.80 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1.521.80 -16 OPM %-73.03-43.33 -PBDT-1.30-0.99 -31 PBT-1.48-1.17 -26 NP-1.29-0.86 -50Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content